All SARS-CoV-2 variants blocked by a simple peptide with nanomolar neutralizing efficacy

In a recent study published in the journal PNAS, researchers from Finland and the United States reported a novel heptad repeat 2 (HR2) peptide that inhibited severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) without any chemical modifications.

Related Keywords

Finland ,United States ,Kateryna Kon ,Coronavirus Disease Covid 19 ,Efficacy ,Cars ,Ars Cov 2 ,Amino Acid ,Ntibody ,Essay ,Fell ,Cell Membrane ,Coronavirus ,Covid 19 ,Luorescence ,Lycoprotein ,Felix ,Embrane ,Monoclonal Antibody ,Utation ,Micron ,Eptides ,Protein ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spike Protein ,Yndrome ,Virus ,